Siga technologies inc (SIGA)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues
Total revenues

2,619

4,264

8,111

3,907

10,459

1,569

471,075

2,661

1,747

-

1,390

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

-

-

-

-

-

-

-

-

-

-

-

4,264

5,201

-

4,658

1,901

1,269

4,188

1,327

1,467

1,192

840

1,099

650

549

934

2,292

964

1,328

2,514

2,289

2,701

1,465

4,960

3,577

2,491

1,696

6,631

4,446

Operating expenses
Cost of sales and supportive services

109

-

-

-

915

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales and supportive services

-

-

737

0

-

102

95,166

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative

3,176

3,496

3,196

3,392

3,166

3,828

3,114

2,880

3,056

3,281

3,093

3,058

2,869

4,463

2,855

3,738

2,656

2,590

2,321

2,592

3,077

2,423

4,334

2,799

3,088

3,706

3,215

3,166

3,031

2,140

3,138

3,474

2,213

6,361

3,969

9,351

4,250

1,389

2,233

Research and development

3,150

3,924

3,343

2,038

3,997

2,972

3,723

3,312

3,007

2,780

2,470

5,067

6,360

8,157

6,068

2,948

2,536

4,937

2,426

2,959

2,807

2,801

2,720

2,371

2,813

2,747

4,260

3,130

3,645

4,395

4,170

5,182

4,464

5,796

5,170

3,835

3,566

7,419

4,929

Patent expenses

182

182

173

182

187

206

186

178

218

221

250

197

240

219

230

239

219

246

194

235

333

169

306

226

285

333

329

300

458

793

376

376

336

571

482

413

341

234

305

Total operating expenses

6,617

-

-

-

8,267

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Litigation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13

-

175,465

-

-

-

50

-

-

-

-

-

-

-

-

-

-

-

-

Lease termination

-

-

-

-

-

-

-

-

-

-

-1,225

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Litigation accrual

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest on PharmAthene liability

-

-

-

-

-

-

-

-

-

-

-

-

-

925

3,566

4,259

2,917

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

PharmAthene liability interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

7,450

5,612

-

7,110

102,190

6,370

6,282

6,283

7,041

8,323

9,470

13,766

12,720

11,186

8,329

22,141

4,955

5,800

6,231

18,394

182,827

5,397

6,187

7,447

7,855

6,597

7,134

7,772

7,685

9,033

7,014

12,729

9,621

13,598

8,158

9,043

7,469

Operating (loss) income

-3,998

-3,469

660

-1,705

2,191

-5,541

368,885

-3,709

-4,534

-4,870

-5,650

-4,058

-4,269

-6,608

-8,062

-9,284

-7,059

-17,952

-3,628

-4,332

-5,039

-17,553

-181,728

-4,746

-5,638

-6,513

-5,563

-5,632

-5,806

-5,258

-5,395

-6,332

-5,548

-7,768

-6,043

-11,107

-6,461

-2,411

-3,022

(Loss) gain from change in fair value of warrant liability

16

-

-

-

-3,136

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of Term Loan

-4,981

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (loss) from change in fair value of warrant liability

-

-

981

656

-

-

-2,328

360

-3,303

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (loss) from change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-295

294

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease (increase) in fair value of common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-129

-156

-

734

-980

974

-1,032

133

-904

999

-4,287

-12,841

-5,543

-1,762

2,018

2,228

Decrease (increase) in fair value of common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

3,016

3,898

3,971

3,971

3,928

3,962

3,924

3,843

3,748

3,759

3,737

3,652

3,608

2,290

94

10

0

-0

0

13

253

86

105

123

140

164

293

376

373

172

0

0

0

-

-

-

-

-

-

Loss from change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-298

300

626

-

1,121

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income, net

412

588

759

737

736

78,789

5

144

2

2

2

8

4

1

30

58

11

13

12

10

5

0

0

1

0

0

0

1

0

0

0

0

0

0

0

14

-2

0

0

Reorganization items, net

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

327

3,389

1,931

1,948

2,149

1,781

1,824

301

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) income before income taxes

-11,600

-6,462

-1,569

-4,282

2,135

-

-

-7,048

-11,584

-12,739

-9,681

-7,408

-8,499

-10,434

-9,247

-9,564

-10,437

-19,870

-5,564

-6,485

-7,069

-19,464

-182,123

-4,723

-5,623

-6,022

-6,592

-5,027

-7,154

-4,398

-5,529

-5,427

-6,548

8,139

-1,316

-9,053

-4,701

-4,430

-5,250

Pre tax loss

-

-

-

-

-

-

362,637

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Benefit (provision) for income taxes

-2,702

-1,959

-363

-1,119

506

15,244

-25,412

2

-2

-2,436

134

92

115

5

-4

1

11

223

65

88

83

-408

57,953

-1,775

-2,241

-1,683

-1,690

-1,966

-2,278

-1,780

-2,470

-1,660

-1,932

-1,596

-1,527

-32,907

0

0

0

Net and comprehensive (loss) income

-8,897

-4,502

-1,205

-3,162

1,629

52,390

388,050

-7,051

-11,582

-10,302

-9,816

-7,501

-8,614

-10,439

-9,243

-9,565

-10,448

-20,094

-5,630

-6,573

-7,153

-19,056

-240,076

-2,948

-3,381

-4,338

-4,901

-3,061

-4,875

-2,618

-3,058

-3,766

-4,615

-1,871

8,326

27,345

-4,701

-4,430

-5,250

Loss per share: basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-0.10

-0.11

-

-0.17

-0.18

-0.19

-0.38

-0.10

-0.12

-0.13

-0.36

-4.49

-0.06

-0.06

-

-0.09

-0.06

-0.09

-

-0.06

-0.07

-0.09

-

-

-

-0.09

-

-

Weighted average shares outstanding: basic and diluted

-

-

-

-

-

-

-

-

-

-

-

78,840

78,777

-

54,284

54,216

54,114

54,097

53,919

53,589

53,504

53,507

53,504

53,414

53,252

-

52,548

52,214

51,714

-

51,639

51,638

51,637

-

-

-

-

-

-

Basic (loss) income per share (in dollars per share)

-0.11

-0.06

-0.01

-0.04

0.02

0.67

4.85

-0.09

-0.15

-

-0.12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.16

0.54

-

-0.10

-0.12

Diluted (loss) per share (in dollars per share)

-0.11

-0.05

-0.03

-0.05

-0.02

0.71

4.71

-0.09

-0.15

-

-0.12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.11

0.40

-

-0.10

-0.12

Weighted average shares outstanding: basic (in shares)

81,240

81,160

81,064

80,986

80,913

81,536

80,023

79,094

79,039

-

78,908

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

50,806

50,879

-

45,509

43,620

Weighted average shares outstanding: diluted (in shares)

81,240

82,264

82,181

82,114

82,139

87,702

82,929

81,163

79,039

-

78,908

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

51,987

54,671

-

45,509

43,620

Net income (loss)

-8,897

-4,502

-1,205

-3,162

1,629

52,390

388,050

-7,051

-11,582

-10,302

-9,816

-7,501

-8,614

-

-9,243

-9,565

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,058

-3,766

-4,615

-1,871

8,326

27,345

-4,701

-4,430

-5,250

Change in net unrealized gain (loss) on short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-4

-

-

-

-

-

-

Comprehensive income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,058

-3,766

-4,619

-

-

-

-

-

-

Weighted average shares outstanding: basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49,959

-

-

Product Sales and Supportive Services [Member]
Total revenues

113

-

-

-

7,142

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and Development [Member]
Total revenues

2,506

-

-

-

3,316

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales and supportive services
Revenue from Contract with Customer, Excluding Assessed Tax

113

132

3,915

0

7,142

53

468,865

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development
Revenue from Contract with Customer, Excluding Assessed Tax

2,506

4,131

4,195

3,907

3,316

1,516

2,210

2,661

1,747

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-